Septerna (SEPN) Other Accumulated Expenses (2023 - 2026)
Septerna's (SEPN) quarterly Other Accumulated Expenses came in at $363000.0 in Q1 2026, up 390.54% year-on-year from $74000.0 in Q1 2025, and up 145.27% quarter-over-quarter from $148000.0 in Q4 2025.
Septerna (SEPN) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Septerna's Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $363000.0 for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses rose 390.54% year-over-year to $363000.0 in Q1 2026; TTM through Mar 2026 was $363000.0, a 390.54% increase from a year earlier, with the FY2025 full-year figure at $148000.0, up 89.74% from the prior year.
- Other Accumulated Expenses advanced to $363000.0 in Q1 2026 per SEPN's latest filing, from $148000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $363000.0 in Q1 2026 and bottomed at $74000.0 in Q1 2025.
- The 4-year median for Other Accumulated Expenses is $98500.0 (2023), against an average of $134625.0.
- Across the five-year window, Other Accumulated Expenses slipped 16.42% in 2025 and soared 390.54% in 2026, its largest moves.
- Year by year, Other Accumulated Expenses stood at $85000.0 in 2023, then dropped by 8.24% to $78000.0 in 2024, then jumped by 89.74% to $148000.0 in 2025, then soared by 145.27% to $363000.0 in 2026.
- Per Business Quant, the three latest SEPN Other Accumulated Expenses figures stand at $363000.0 (Q1 2026), $148000.0 (Q4 2025), and $112000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Septerna | 1.49 Bn | 1.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 363,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | 134,000.00 |
| Dec 31, 2023 | 85,000.00 |